27 February 2020 in Molecular and Cellular Biochemistry
9 January 2020 in Journal of the American Society for Mass Spectrometry
11 May 2018 in Journal of Voice
26 November 2021 in Biomedical Chromatography
4 February 2025 in Toxicology and Industrial Health
Pesticides, widely used for insect control in agriculture, public health, and veterinary medicine, are usually present as pollutants in aquatic environments. After contamination of water bodies, pesticides cause adverse effects on non-target organisms and long-term problems in the ecosystem. Lambda-cyhalothrin (LCH) is a chemical compound belonging to the family of synthetic pyrethroids (type II) and is an active ingredient in several insecticides. This study investigated the toxic effects (DNA damage) of LCH exposure on zebrafish for 24 and 72 h. After zebrafish ( Danio rerio) were obtained commercially, acclimated, and adapted to laboratory conditions. They were randomly selected, transferred to the experimental aquariums (their average height is 2.51 ± 0.49 cm long, 10 L aquarium size of 10x20x35), and exposed to 0.1 mg/L LCH concentrations for 24 and 72 h. There was also a control and a solvent control group in the study, and whole body tissues of zebrafish were analyzed for 8-hydroxy-2-deoxyguanosine (8-OhdG) determination (ng/100 mg tissue), using an Agilent LC-MS/MS with electrospray ionization in positive ion mode. It was observed that the whole-body 8-OHdG tissue values were significantly increased in the group exposed to LCH for 72 h (9.82 ± 1.44) compared with the control group (6.60 ± 1.78, p = .004). These results suggest that LCH could lead to oxidative DNA damage by causing an increase in 8-OHdG activities in zebrafish, one of the aquatic ecosystem model organisms, indicating that it may also cause undesirable effects on other non-target species.
20 September 2021 in Journal of Basic and Clinical Health Sciences
Dry eye is both a common symptom and a disease. It is known that the ophthalmic emulsion of the immunomodulator cyclosporine-A (Cyc-A) has a positive effect on this condition but its’ absorption to intraocular tissues is limited. Nanosuspension is a drug formulation that aims to increase the bioavailability. The aim of this study was to develop a Cyc-A nanosuspension formulation for a better intraocular absorption via ocular delivery and to investigate the effectiveness of the formulation by comparing it with two marketed ophthalmic emulsions (Restasis® and Depores®). Two type of Cyc-A loaded Eudragit S100 nanosuspension (A and B) were prepared. Drug formulations were applied to both eyes of 20 male Albino New Zealand rabbits with an interval of 12 hours for 14 days. In vitro drug release was tested using a dialysis sac and quantitative analysis was performed by HPLC for evaluating Cyc-A amounts in all formulations. Although all four formulations had similar particle size and polydispersity indexes, nanosuspension B which had a positive zeta potential value, had released more Cyc-A than other formulations. It was showed that Cyc-A loaded nanosuspension formulations which had good ocular tolerability could be a better alternative to commercial formulations for the treatment of dry eye. The nanosuspensions have ideal mean particle size range with a positive surface charge for ophthalmic applications of Cyc-A.